Date | Time | Source | Announcement |
---|---|---|---|
23 Jun 2011 | 07:00 AM | AGM Statement | |
21 Jun 2011 | 07:00 AM | GeneICE Update | |
10 Jun 2011 | 07:00 AM | Volition - update | |
02 Jun 2011 | 07:00 AM | Directorate Change | |
31 May 2011 | 01:30 PM | Publication of Report & Accounts and Notice of AGM | |
31 May 2011 | 07:00 AM | Final Results | |
31 May 2011 | 07:00 AM | Total Voting Rights | |
26 May 2011 | 02:56 PM | Holding(s) in Company | |
20 May 2011 | 07:00 AM | Website update | |
14 Apr 2011 | 07:00 AM | Agreements with Imperial College & Oxford Uni | |
04 Apr 2011 | 07:00 AM | Re Self-Test Health Report | |
24 Mar 2011 | 10:00 AM | SELFCheck Update | |
09 Mar 2011 | 02:54 PM | Holding(s) in Company | |
09 Mar 2011 | 11:15 AM | Holding(s) in Company | |
07 Mar 2011 | 10:56 AM | Result of EGM | |
07 Mar 2011 | 07:00 AM | Statement re General Meeting | |
25 Feb 2011 | 02:09 PM | Website Update | |
18 Feb 2011 | 02:54 PM | Publication of Circular and Notice of GM | |
16 Feb 2011 | 07:19 AM | Issue of Equity | |
14 Feb 2011 | 07:00 AM | Update | |
01 Feb 2011 | 11:38 AM | Total Voting Rights | |
31 Jan 2011 | 07:00 AM | Further re Sale of Belgian Su | |
27 Jan 2011 | 07:00 AM | Issue of Equity | |
26 Jan 2011 | 10:58 AM | Result of General Meeting | |
11 Jan 2011 | 07:00 AM | Publication of Circular and N | |
02 Dec 2010 | 07:00 AM | Update - Eurostars Programme | |
01 Dec 2010 | 07:00 AM | Total Voting Rights | |
10 Nov 2010 | 07:00 AM | Issue of equity and update | |
01 Nov 2010 | 04:12 PM | Total Voting Rights | |
29 Oct 2010 | 03:16 PM | Issue of Equity | |
29 Oct 2010 | 03:15 PM | Change of Adviser | |
11 Oct 2010 | 10:51 AM | Completion of Disposal | |
30 Sep 2010 | 02:17 PM | Half Yearly Report | |
23 Sep 2010 | 07:00 AM | Disposal | |
31 Aug 2010 | 07:00 AM | Total Voting Rights | |
16 Aug 2010 | 05:12 PM | Issue of Equity | |
12 Aug 2010 | 07:00 AM | Licensing Deal with Cancer Re | |
15 Jul 2010 | 07:00 AM | HPV Test Starts Clinical Vali | |
30 Jun 2010 | 10:15 AM | Result of AGM | |
17 Jun 2010 | 07:00 AM | Eurostars' GeneICE Programme | |
17 Jun 2010 | 07:00 AM | GeneICE Update | |
07 Jun 2010 | 07:00 AM | Final Results | |
24 May 2010 | 07:00 AM | Re Agreement | |
30 Apr 2010 | 02:47 PM | Total Voting Rights | |
21 Apr 2010 | 04:08 PM | Issue of Equity - Replacement | |
21 Apr 2010 | 03:14 PM | Result of General Meeting | |
01 Apr 2010 | 03:19 PM | Proposed reorg of share capit | |
01 Apr 2010 | 10:06 AM | Issue of Equity | |
01 Apr 2010 | 10:06 AM | Trading Update | |
31 Mar 2010 | 07:00 AM | Total Voting Rights |
ValiRx PLC: A Biotech Innovator on the London Stock Exchange (LSE)
ValiRx PLC, known by its ticker symbol VAL, is a trailblazer in the biotechnology sector. Its performance on the London Stock Exchange (LSE) has been remarkable, with the ValiRx share price reflecting the company's consistent growth and success.
As a member of the LSE, ValiRx PLC aligns with the London Stock Exchange Group's (LSEG) mission of supporting innovative and growing businesses. The LSEG recognises ValiRx PLC as a significant player, contributing to the robust and diverse ecosystem of the LSE.
The ValiRx share price on the LSE not only underscores its financial stability but also its strategic vision in the biotechnology industry. ValiRx PLC's journey on the LSE is a testament to its robust business model and its ability to create value for its stakeholders.
In conclusion, ValiRx PLC's association with the LSE and LSEG symbolises its commitment to growth, innovation, and value creation. As ValiRx PLC continues to thrive on the LSE, it sets the bar high for the biotechnology industry, contributing to the dynamic and diverse ecosystem of the LSEG. With its focus on cancer therapeutics, ValiRx is a key player in the healthcare sector, making strides in medical research and development.